| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000263011.1 |
Ponatinib |
Breast invasive carcinoma |
0.022156194 |
Resistant |
| ENSG00000263011.1 |
Ponatinib |
Brain lower grade glioma |
0.032019988 |
Resistant |
| ENSG00000263011.1 |
Ponatinib |
Colon adenocarcinoma |
0.008590806 |
Resistant |
